Search Results

You are looking at 1 - 2 of 2 items for :

  • "receptor activator of nuclear factor kappa-β ligand" x
Clear All
Restricted access

Panagiota Klentrou, Kirina Angrish, Nafisa Awadia, Nigel Kurgan, Rozalia Kouvelioti and Bareket Falk

inhibition of bone formation ( 34 ). In addition to inhibiting the canonical Wnt signaling pathway, sclerostin can also stimulate the secretion of receptor activator of nuclear factor kappa-β ligand (RANKL) from osteocytes and induce osteoclastogenesis ( 40 , 43 ). RANKL is a catabolic osteokine that binds

Restricted access

Jennifer Dekker, Katlynne Nelson, Nigel Kurgan, Bareket Falk, Andrea Josse and Panagiota Klentrou

; RANKL, receptor activator of nuclear factor kappa-β ligand; SOST, sclerostin; TGF-β1, transforming growth factor-β1; TGF-β2, transforming growth factor-β2; TGF-β3, transforming growth factor-β3. *Significant difference between groups. Regarding the Wnt inhibitors, SOST showed a significant main effect